share_log

23% Of This Select Medical Holdings Insider's Holdings Were Sold

23% Of This Select Medical Holdings Insider's Holdings Were Sold

该精选医疗控股公司内幕持股中有 23% 已出售
Simply Wall St ·  2023/12/15 19:21

From what we can see, insiders were net sellers in Select Medical Holdings Corporation's (NYSE:SEM ) during the past 12 months. That is, insiders sold the stock in greater numbers than they purchased it.

据我们所见,在过去的12个月中,内部人士是Select Medical Holdings Corporation(纽约证券交易所代码:SEM)的净卖家。也就是说,内部人士出售股票的数量超过了他们购买的数量。

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

尽管在长期投资方面,内幕交易并不是最重要的事情,但我们确实认为密切关注内部人士的所作所为是完全合乎逻辑的。

See our latest analysis for Select Medical Holdings

查看我们对精选医疗控股的最新分析

Select Medical Holdings Insider Transactions Over The Last Year

精选去年的医疗控股内幕交易

Over the last year, we can see that the biggest insider sale was by the Senior Vice President of Compliance & Audit, Robert Breighner, for US$296k worth of shares, at about US$29.45 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The good news is that this large sale was at well above current price of US$24.94. So it may not shed much light on insider confidence at current levels. Robert Breighner was the only individual insider to sell over the last year.

在过去的一年中,我们可以看到,最大的内幕出售是合规与审计高级副总裁罗伯特·布雷纳,出售了价值29.6万美元的股票,每股约29.45美元。虽然我们通常不喜欢看到内幕销售,但更令人担忧的是是否以较低的价格进行销售。好消息是,此次大宗销售远高于当前的24.94美元价格。因此,在当前水平上,这可能无法为内部信心提供太多启示。罗伯特·布雷纳是去年唯一一位出售股票的内部人士。

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

您可以看到下图所示的去年的内幕交易(公司和个人)。通过点击下面的图表,你可以看到每笔内幕交易的确切细节!

insider-trading-volume
NYSE:SEM Insider Trading Volume December 15th 2023
纽约证券交易所:SEM 内幕交易量 2023 年 12 月 15 日

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

对于那些喜欢寻找中奖投资的人来说,这份最近有内幕收购的成长型公司的免费名单可能只是门票。

Does Select Medical Holdings Boast High Insider Ownership?

Select Medical Holdings是否拥有很高的内幕

Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Select Medical Holdings insiders own about US$572m worth of shares (which is 18% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

许多投资者喜欢检查公司有多少股份由内部人士拥有。我认为,如果内部人士拥有该公司的大量股份,那将是一个好兆头。精选医疗控股内部人士拥有价值约5.72亿美元的股份(占该公司的18%)。我喜欢看到这种程度的内部所有权,因为它增加了管理层考虑股东最大利益的机会。

So What Does This Data Suggest About Select Medical Holdings Insiders?

那么,这些数据对精选的医疗控股内部人士有什么启示呢?

It doesn't really mean much that no insider has traded Select Medical Holdings shares in the last quarter. It's heartening that insiders own plenty of stock, but we'd like to see more insider buying, since the last year of Select Medical Holdings insider transactions don't fill us with confidence. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To help with this, we've discovered 2 warning signs (1 is a bit concerning!) that you ought to be aware of before buying any shares in Select Medical Holdings.

上个季度没有内部人士交易过Select Medical Holdings的股票,这并不意味着什么。令人鼓舞的是,内部人士拥有大量股票,但我们希望看到更多的内幕买盘,因为去年Select Medical Holdings的内幕交易并没有使我们充满信心。因此,尽管了解内部人士在买入或卖出方面的所作所为很有帮助,但了解特定公司面临的风险也很有帮助。为了帮助解决这个问题,我们发现了 2 个警告标志(1 个有点令人担忧!)在购买Select Medical Holdings的任何股票之前,你应该意识到这一点。

Of course Select Medical Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,精选医疗控股可能不是最值得购买的股票。因此,您可能希望看到这个免费的高质量公司集合。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是那些向相关监管机构报告交易的个人。我们目前仅对公开市场交易和直接权益的私人处置进行核算,但不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是笼统的。我们仅使用公正的方法提供基于历史数据和分析师预测的评论,我们的文章并非旨在提供财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不会考虑最新的价格敏感型公司公告或定性材料。华尔街只是没有持有上述任何股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发